PMID- 20445448 OWN - NLM STAT- MEDLINE DCOM- 20100830 LR - 20100521 IS - 1531-7013 (Electronic) IS - 1087-2418 (Linking) VI - 15 IP - 3 DP - 2010 Jun TI - Current status of living donor small bowel transplantation. PG - 346-8 LID - 10.1097/MOT.0b013e3283398fa4 [doi] AB - PURPOSE OF REVIEW: To analyze the current status of living donor intestinal transplantation (LDIT) as a treatment option for intestinal failure. RECENT FINDINGS: Long-term outcomes from LDIT and combined living donor intestinal/liver transplantation (CLDILT) are comparable with those from transplantation using deceased donors. In certain life-threatening situations, especially in pediatric patients, this strategy may offer potential advantages. SUMMARY: According United Network for Organ Sharing (UNOS) data children with intestinal failure affected by liver disease secondary to parenteral nutrition have the highest mortality on a waiting list compared with all candidates for solid organ transplantation. Elective nature of CLDILT offers multiple advantages for this patient population. LDIT also could be life-saving option for patients with intestinal failure who run out of venous access. Optimal timing, short ischemia time and good human leukocyte antigen (HLA) matching may contribute to lower postoperative complications. Current literature suggests that living intestinal donors experience very low morbidity and high level of satisfaction. FAU - Tzvetanov, Ivo G AU - Tzvetanov IG AD - Division of Transplantation, Department of Surgery, University of Illinois at Chicago, Illinois, USA. FAU - Oberholzer, Jose AU - Oberholzer J FAU - Benedetti, Enrico AU - Benedetti E LA - eng PT - Journal Article PT - Review PL - United States TA - Curr Opin Organ Transplant JT - Current opinion in organ transplantation JID - 9717388 SB - IM MH - Child MH - Child, Preschool MH - Humans MH - Infant MH - Intestine, Small/*transplantation MH - Liver Failure/etiology/mortality/*surgery MH - *Liver Transplantation/adverse effects/mortality MH - Living Donors/*supply & distribution MH - Parenteral Nutrition, Total/adverse effects MH - Patient Selection MH - Risk Assessment MH - Risk Factors MH - Short Bowel Syndrome/mortality/*surgery MH - Time Factors MH - Treatment Outcome MH - Waiting Lists RF - 24 EDAT- 2010/05/07 06:00 MHDA- 2010/08/31 06:00 CRDT- 2010/05/07 06:00 PHST- 2010/05/07 06:00 [entrez] PHST- 2010/05/07 06:00 [pubmed] PHST- 2010/08/31 06:00 [medline] AID - 10.1097/MOT.0b013e3283398fa4 [doi] PST - ppublish SO - Curr Opin Organ Transplant. 2010 Jun;15(3):346-8. doi: 10.1097/MOT.0b013e3283398fa4.